Dr. Cobb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1315 Golden Valley Circle
Billings, MT 59102Phone+1 406-670-3721Fax+1 406-238-6280
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1988 - 1991
Fitzsimons Army Medical CenterResidency, Internal Medicine, 1985 - 1988
Tulane University School of MedicineClass of 1985
Certifications & Licensure
MT State Medical License 1995 - 2025
WY State Medical License 1995 - 2025
GA State Medical License 1992 - 1995
LA State Medical License 1985 - 1991- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Publications & Presentations
PubMed
- 4 citationsActivity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative a...Carlo Palmieri, Hannah Linden, Stephen N Birrell, Sally Wheelwright, Elgene Lim
The Lancet. Oncology. 2024-03-01 - 21 citationsOvercoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.Marc S Hoffmann, Bradley D Hunter, Patrick W Cobb, Juan C Varela, Javier Munoz
Transplantation and Cellular Therapy. 2023-07-01 - 1 citationsA review of the totality of evidence in the development of ABP 798, a rituximab biosimilar.Patrick Cobb, Dietger Niederwieser, Stanley Cohen, Caroline Hamm, Gerd Burmester
Immunotherapy. 2022-06-01
Press Mentions
Holy Rosary Healthcare Announces Construction of Comprehensive Cancer Center Serving Eastern MontanaJanuary 30th, 2023
Phase 2 Study of Duvelisib in Previously Treated Patients with Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (BRIO)December 12th, 2017- Initial Reactions to the Oncology Care ModelMarch 25th, 2015
Grant Support
- Montana Cancer ConsortiumNational Cancer Institute2000–2004
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
